{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T06:41:57Z","timestamp":1703918517101},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1006\/taap.1997.8330","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T22:01:25Z","timestamp":1032386485000},"page":"41-48","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacodynamic Responses of F344 Rats to the Mouse Hepatocarcinogen Oxazepam in a 90-Day Feed Study"],"prefix":"10.1006","volume":"149","author":[{"given":"Michael L.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/taap.1997.8330_TO978330RF1","first-page":"40","article-title":"Pharmacokinetics of oxazepam in healthy volunteers","volume":"40","author":"Alvan","year":"1977","journal-title":"Acta Pharmicol. Toxicol."},{"key":"10.1006\/taap.1997.8330_TO978330RF2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/096032719401300201","article-title":"Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis","volume":"13","author":"Ashby","year":"1994","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1006\/taap.1997.8330_TO978330RF3","first-page":"3246","article-title":"Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver","volume":"49","author":"Cattley","year":"1989","journal-title":"Cancer Res."},{"key":"10.1006\/taap.1997.8330_TO978330RF4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-1110(96)90012-3","article-title":"Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens","volume":"365","author":"Cunningham","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1006\/taap.1997.8330_TO978330RF5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0041-008X(91)90319-A","article-title":"Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair-2,6-and 2,4-diaminotoluene","volume":"107","author":"Cunningham","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1997.8330_TO978330RF6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0041-008X(91)90050-O","article-title":"Relationship of hepatocarcinogenicity and hepatocellular proliferation induced by mutagenic noncarcinogens vs carcinogens. II. 1- vs 2-Nitropropane","volume":"110","author":"Cunningham","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1997.8330_TO978330RF7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/taap.1994.1005","article-title":"Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam","volume":"124","author":"Cunningham","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1997.8330_TO978330RF8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/faat.1994.1116","article-title":"Relationship of carcinogenicity and cellular proliferation induced by mutagenic noncarcinogens vs carcinogens. III. Organophosphate pesticides vstris","volume":"23","author":"Cunningham","year":"1994","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1006\/taap.1997.8330_TO978330RF9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/carcin\/10.7.1345","article-title":"Promotion of malignant \u2018embryonal\u2019 liver tumors by phenobarbital: increased incidence and shortened latency of hepatoblastomas in (DBA\/2 \u00d7 C57BL\/6)F1 mice initiated withN","volume":"10","author":"Diwan","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1006\/taap.1997.8330_TO978330RF10","first-page":"188","article-title":"Liver-cell adenomas and peliosis hepatis in mice associated with oxazepam","volume":"8","author":"Fox","year":"1974","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1006\/taap.1997.8330_TO978330RF11","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Gilman","year":"1990"},{"key":"10.1006\/taap.1997.8330_TO978330RF12","first-page":"918","article-title":"Metabolism and elimination of oxazepam in B6C3F1 and Swiss-Webster mice","volume":"21","author":"Griffin","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1006\/taap.1997.8330_TO978330RF13","first-page":"232","article-title":"Metabolism and elimination of oxazepam in F344 rats","volume":"23","author":"Griffin","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1006\/taap.1997.8330_TO978330RF14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/096032719501401001","article-title":"Oxidative biotransformation of oxazepam to reactive and nonreactive products in rat, mouse and human microsomes","volume":"14","author":"Griffin","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1006\/taap.1997.8330_TO978330RF15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-4274(95)80010-B","article-title":"Induction of hepatic drug metabolizing enzymes by prechronic oxazepam-dosed feed treatment in B6C3F1 mice","volume":"76","author":"Griffin","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1006\/taap.1997.8330_TO978330RF16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/faat.1996.0016","article-title":"Hepatic cell proliferation, enzyme activities and altered serum thyroid-stimulating hormone levels following oxazepam-dosed feed treatment in B6C3F1 mice","volume":"29","author":"Griffin","year":"1996","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1006\/taap.1997.8330_TO978330RF17","series-title":"Chemically Induced Cell Proliferation: Implications for Risk Assessment","article-title":"Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis","author":"Klaunig","year":"1991"},{"key":"10.1006\/taap.1997.8330_TO978330RF18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/019262339602400611","article-title":"The contribution of the mouse in hazard identification studies","volume":"24","author":"Maronpot","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1006\/taap.1997.8330_TO978330RF19","year":"1993","journal-title":"Toxicology and Carcinogenesis Studies of Oxazepam in Swiss-Webster and B6C3F1 Mice"},{"key":"10.1006\/taap.1997.8330_TO978330RF20","year":"1996","journal-title":"Toxicology and Carcinogenesis Studies of Oxazepam in F344\/N Rats"},{"key":"10.1006\/taap.1997.8330_TO978330RF21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2362.1975.tb00439.x","article-title":"Hepatic cholesterol synthesis in man: Effect of diazepam and other drugs","volume":"5","author":"Orlandi","year":"1975","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1006\/taap.1997.8330_TO978330RF22","series-title":"Physicians' Desk Reference","year":"1990"},{"key":"10.1006\/taap.1997.8330_TO978330RF23","first-page":"41","article-title":"The metabolic disposion of oxazepam in rats","volume":"14","author":"Sisenwine","year":"1986","journal-title":"Drug Metab. Dispos."},{"key":"10.1006\/taap.1997.8330_TO978330RF24","first-page":"682","article-title":"The biotransformation of oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one) in man, miniature swine and rat","volume":"22","author":"Sisenwine","year":"1972","journal-title":"Arzn.Forsch."},{"key":"10.1006\/taap.1997.8330_TO978330RF25","series-title":"Chemically Induced Cell Proliferation: Implications for Risk Assessment","first-page":"285","article-title":"Evaluation of bromodeoxyuridine labeling in hepatomegaly produced by peroxisomal proliferation or P-450 induction in rodents","author":"Smith","year":"1991"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X97983307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X97983307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T06:01:33Z","timestamp":1703916093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X97983307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["S0041008X97983307"],"URL":"https:\/\/doi.org\/10.1006\/taap.1997.8330","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}